Production (Stage)
MiNK Therapeutics, Inc.
INKT
$7.26
-$0.035-0.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.33% | -36.34% | 33.13% | 29.15% | 30.14% |
| Total Depreciation and Amortization | -5.75% | -13.90% | 38.80% | -16.17% | 0.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.52% | 159.03% | -367.22% | -25.28% | -45.86% |
| Change in Net Operating Assets | 2,861.68% | 64.33% | 24.62% | -112.82% | -51.02% |
| Cash from Operations | 22.39% | 42.31% | -30.74% | 9.89% | 16.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.88% | 84,049.28% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -99.88% | 15.97% | -- |
| Foreign Exchange rate Adjustments | 92.34% | -970.37% | 114.21% | -28.38% | -444.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.36% | 41.34% | -185.38% | 42.72% | 180.81% |